by Marlene Zepeda, UC San Diego

The UC San Diego Hemophilia and Thrombosis Treatment Center is offering a three-day course on musculoskeletal ultrasound (MSKUS) and joint injection. The course is free to providers connected with HTCs and CME credits will be earned by participants. For more information on the course and to register for the course check out this link.

The goal of the Innovation Grant is to encourage larger scale, unique, and innovative projects that will serve the community with resources that will improve the lives of patients with inherited bleeding and thrombotic disorders.

To be eligible the applicant organization must serve persons with heritable bleeding and thrombotic disorders and operate under IRS tax exemption 501(c)(3) or 170(c)(1) or other nonprofit status. Eligible organizations would include:

• Local applicants such as chapters, member organizations, and HTCs
• National organizations
• The eight HHS-designated federally-funded regional core coordinating centers.

The maximum amount per grant request is $50,000. Projects should demonstrate clear and measurable outcomes.

Priority for funding will be given to new projects aimed at expansion of capacity, collaboration (between two or more organizations), and innovation.

Organizations interested in submitting applications should review the 2023 Grant Guidance thoroughly before finalizing their applications. To see our Grant Guidance and to apply online, visit our website at: https://hemophiliaalliancefoundation.org/grant-information

The deadline for application submission is July 18th, 2023. Applications must be submitted directly on the Hemophilia Alliance Foundation website.

For questions about the Innovation Grant process, please contact the Hemophilia Alliance Foundation Grant Committee Chairman, Ralph Gruppo, MD – ralph.gruppo@fuse.net